MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Chenodeoxycholic acid

Chenodeoxycholic acid 200mg tablets

No stability information

Stability notes for Chenodeoxycholic acid 200mg tablets

There are no stability notes for this medicine.

Supplier

Chenodeoxycholic acid 200mg tablets (Special Order)

Chenodeoxycholic acid 250mg capsules

No stability information

Stability notes for Chenodeoxycholic acid 250mg capsules

There are no stability notes for this medicine.

Supplier

Chenodeoxycholic acid 250mg capsules (Leadiant Biosciences Ltd)

Chenodeoxycholic acid 250mg tablets

No stability information

Stability notes for Chenodeoxycholic acid 250mg tablets

There are no stability notes for this medicine.

Supplier

Chenodiol 250mg tablets (Imported (Canada))

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.